PlaqueTec and RxCelerate collaborate on early phase drug discovery for coronary artery disease
2 min read
admin
September 18, 2024
PlaqueTec Sep 18 2024 PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease (CAD), and...
